Crescent Biopharma (CBIO) shares fell 5.4% on Monday after HC Wainwright downgraded the stock to neutral from buy.
Trading volume stood at around 254,676 shares compared with a daily average of 264,600.
Price: $19.53, Change: $-1.12, Percent Change: -5.42%